Fact CheckerSign in

NCT06886477Completed

Sickle Cell, Pain and Mediterranean Diet

Exploring the Mediterranean Diet as A Promising Approach for Alleviating Chronic Pain in Sickle Cell Disease

Source: ClinicalTrials.gov · Last updated 13 Jul 2026

Brief summary (registry, in English)

The goal of this study is to compare pain levels in individuals with Sickle Cell Disease while following the Mediterranean Diet to pain levels while following their usual diet.

Status (registry)
Completed
Study type
Interventional
Enrollment
37 (actual)
First submitted
11 Mar 2025
Start date
1 May 2025
Primary completion date
9 Jul 2026
Lead sponsor
University of Illinois Chicago
NCT number
NCT06886477

What you commit to

  • Study type: Interventional
  • Participants enrolled: 37
  • From 1 May 2025 to the primary completion date, 9 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having taken systemic antimicrobials (to treat an infection in the previous 4 weeks)
  • Currently receiving dialysis treatment

Other illness

  • History of colon cancer or inflammatory bowel disease (given potential untoward effects on the gut microbiome)
  • History of Clostridium difficile infection in the preceding 12 weeks;
  • Currently following a Mediterranean diet, vegan diet, or dietary restrictions (e.g., religious, food intolerance/allergy) that preclude adoption of a Mediterranean diet

Other

  • Unable to agree to maintain physical activity at the current level for the duration of the study
  • Lack of access to a space to safely store and reheat food items
  • Living in a facility that provides meals.
  • Pregnancy or breastfeeding
  • More than 7 in-patient hospital stays in the last year

Who the study is looking for

  • Sickle Cell Disease Diagnosis
  • Chronic non-vaso-occlusive pain experienced on average ≥ 3 days per week for \> 6 months (based on a response of "Most days," "Every day," or "Some days" and not "Never" to the question "In the past 6 months, how often have you had pain?")
  • Ability to speak, read, write, and understand English
  • A Mediterranean Eating Pattern for Americans (MEPA-III) score \<13, indicating that they do not follow a Mediterranean diet.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Illinois Chicago
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.